AI assistant
Dare Bioscience, Inc. — Director's Dealing 2014
Apr 10, 2014
34825_dirs_2014-04-10_34653d02-7157-4864-b488-3952f58afd29.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2014-04-10
Reporting Person: Crane Family Irrevocable Trust- 2002 (10% Owner)
Reporting Person: Crane Howard R. (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 82716 | Direct |
| Common Stock | 82716 | Indirect |
Footnotes
F1: Reflects a 1-for-14.5074 reverse stock split effected on March 31, 2014.
F2: Represents the shares of Common Stock owned of record by The Crane Family Irrevocable Trust-2002.
F3: Represents the shares of Common Stock owned of record by The Crane Family Irrevocable Trust-2002 and beneficially by Howard Crane. Mr. Crane is the trustee of the The Crane Family Irrevocable Trust-2002 and has voting and dispositive control over any securities owned of record or beneficially by The Crane Family Irrevocable Trust-2002. Therefore, Mr. Crane may be deemed to beneficially own the shares of Common Stock held by The Crane Family Irrevocable Trust-2002.